Insights

Strategic Expansion BioNTech is expanding manufacturing and research capacity internationally, including a new state-of-the-art clinical-scale mRNA facility at La Trobe University in Australia and collaborations with African Union and Africa CDC to deploy BioNTainer systems. This creates opportunities to offer scalable manufacturing, clinical research support, and local training services.

Public–Private Partnerships Active government and regional partnerships in Victoria, Australia, and Africa indicate a favorable policy and funding environment for life sciences projects. Sales opportunities exist for technology transfer, sovereign manufacturing capabilities, and ecosystem development services.

Personalized mRNA BioNTech is advancing personalized mRNA therapies in collaboration with Roche Genentech, including pancreatic cancer programs. This signals a market need for specialized bioprocessing, data analytics, and compliant clinical development platforms that support precision immunotherapies.

Digital & Enterprise The tech stack includes Microsoft Azure, Salesforce, Power Apps, and Qualtrics, indicating an ongoing modernization of operations, CRM, and patient/employee insights. Potential upsell of cloud-based data integration, analytics, regulatory compliance tooling, and digital workflow optimization.

Financial Signals Revenue is in the multi-billion range with significant funding, while recent quarterly results show volatility. This suggests a need for scalable, cost-efficient solutions in manufacturing, supply chain transparency, and strategic partnerships that enable lean operations and risk management.

Similar companies to BioNTech SE

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including Microsoft Power Apps, AutoCAD, Salesforce, and more. Explore BioNTech SE's tech stack below.

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 6 email formats:
BioNTech SE Email FormatsExamplePercentage
First.Last@biontech.comJohn.Doe@biontech.com
95%
FLast@biontech.comJDoe@biontech.com
5%
First.Last@biontech.deJohn.Doe@biontech.de
90%
FLast@biontech.deJDoe@biontech.de
6%
LF@biontech.deDJ@biontech.de
2%
Last.First@biontech.deDoe.John@biontech.de
2%

Frequently Asked Questions

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon
You can contact BioNTech SE's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign icon
BioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign icon
BioNTech SE's official website is biontech.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon
As of October 2026, BioNTech SE's annual revenue is estimated to be $1B - $10B.

What is BioNTech SE's SIC code and NAICS code?

Minus sign iconPlus sign icon
BioNTech SE's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign icon
As of October 2026, BioNTech SE has approximately 5.2K employees across 6 continents, including Europe, North America and Asia. Key team members include Chief Executive Officer & Co-Founder: U. S., Chief Executive Officer: H. B. and Ceo: F. K. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign icon
BioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign icon
BioNTech SE's tech stack includes Microsoft Power Apps, AutoCAD, Salesforce, ADP Workforce Now, Microsoft Active Directory, Qualtrics, Microsoft Azure and Atlassian Confluence.

What is BioNTech SE's email format?

Minus sign iconPlus sign icon
BioNTech SE's email format typically follows the pattern of First.Last@biontech.com. Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon
As of October 2026, BioNTech SE has raised $2B in funding. The last funding round occurred on Oct 13, 2025 for $70M.

When was BioNTech SE founded?

Minus sign iconPlus sign icon
BioNTech SE was founded in 2008.
BioNTech SE logo

BioNTech SE

Biotechnology ResearchRhineland-palatinate, Germany5001-10000 Employees

BioNTech SE is a global biotechnology company that develops immunotherapies designed to harness the immune system to treat cancer and infectious diseases, with a focus on mRNA technologies. It is headquartered in Mainz, Germany, at 12 An der Goldgrube, Mainz, Rhineland-Palatinate 55131. The company was founded in 2008 by scientists and physicians to translate science into survival and has conducted fundamental research in mRNA technologies for individualized cancer medicine for more than a decade. BioNTech operates globally and employs between 5,001 and 10,000 people. Its website is https://biontech.com.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
5001-10000

Section iconFunding & Financials

  • $2B

    BioNTech SE has raised a total of $2B of funding over 12 rounds. Their latest funding round was raised on Oct 13, 2025 in the amount of $70M as a Grant.

  • $1B - $10B

    BioNTech SE's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.